MYC and neoplasm: To assess the tumor suppressive activity of nuclear DLC1 in vivo, we performed stable retroviral expression of nuclear targeted Myc-tagged mouse DLC1 in a p53 null mouse hepatoblasts with constitutive RasV12 activation [11].